1-hydroxy-3-amino-2-pyrrolidone has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanthasamy, A; Kanthasamy, AG; Matsumoto, RR; Truong, DD; Vu, TQ | 1 |
1 other study(ies) available for 1-hydroxy-3-amino-2-pyrrolidone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Neuroprotective effects of the strychnine-insensitive glycine site NMDA antagonist (R)-HA-966 in an experimental model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain; Dopamine; Dopamine Agents; Drug Resistance; Excitatory Amino Acid Agonists; Glycine Agents; Male; Mice; Mice, Inbred C57BL; N-Methylaspartate; Neurons; Neuroprotective Agents; Parkinson Disease, Secondary; Pyrrolidinones; Stereoisomerism; Strychnine | 1997 |